Filing Details

Accession Number:
0000899243-18-015118
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-05 16:48:21
Reporting Period:
2018-06-01
Accepted Time:
2018-06-05 16:48:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492674 T2 Biosystems Inc. TTOO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1292650 B David Elsbree 101 Hartwell Ave
Lexington MA 02421
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-02 18,000 $0.00 68,000 No 4 M Direct
Common Stock Acquisiton 2018-06-01 4,225 $7.65 10,000 No 4 P Indirect By spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 P Indirect By spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2017-06-02 18,000 $0.00 18,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,000 No 4 M Direct
Footnotes
  1. The restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
  2. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  3. On June 2, 2017 the reporting person was granted 18,000 RSUs that vested on June 2, 2018.